XM does not provide services to residents of the United States of America.

Nobel chemistry prize 2024 goes to trio of protein pioneers



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 4-Nobel chemistry prize 2024 goes to trio of protein pioneers</title></head><body>

Rewrites first paragraph, adds age of laureates, quotes in paragraphs 3, 5 and 10

Baker, Hassabis and Jumper win Nobel chemistry prize

Prize awarded for work on building blocks of life

U.S. professor Baker developed tools to create new proteins

Google DeepMind scientists Hassabis and Jumper used AI to predict protein structures

Chemistry third award in this year's Nobel line-up

By Johan Ahlander, Niklas Pollard

STOCKHOLM, Oct 9 (Reuters) -U.S. Scientists David Baker and John Jumper and Briton Demis Hassabis won the 2024 Nobel Prize in Chemistry on Wednesday for work on decoding the structure of proteins and creating new ones, yielding advances in areas such as drug development.

Half the prize was awarded to Baker "for computational protein design" while the other half was shared by Hassabis and Jumper "for protein structure prediction", said the Royal Swedish Academy of Sciences, which makes the award.

Baker, 62, is a professor at the University of Washington, in Seattle, while Hassabis, 48, is CEO of Google DeepMind, the AI research subsidiary of Google GOOGL.O, where Jumper, 39, also works as senior research scientist.

Hassabis and Jumper utilised artificial intelligence to predict the structure of almost all known proteins, while Baker learned how to master life's building blocks and create entirely new proteins, the award-giving body said.

"This is a monumental achievement for AI, for computational biology, and science itself," Google DeepMind said on X.

The award is the second this week given for work involving artificial intelligence, underscoring the growing importance of machine learning and large language models for science.

"One of the discoveries being recognised this year concerns the construction of spectacular proteins," the academy said in a statement. "The other is about fulfilling a 50-year-old dream: predicting protein structures from their amino acid sequences."

The prize, widely regarded as among the most prestigious in the scientific world, is worth 11 million Swedish crowns ($1.1 million).

'SPECTACULAR NEW PROTEINS'

Baker said he was asleep when the phone rang and he got the announcement.

"Then my wife began screaming very loudly so I couldn't really hear very well," Baker said by phone to the press conference announcing the prize.

"I'm really excited about all the ways in which protein design makes the world a better place in health, medicine and really, outside technology," he said.

In 2003, Baker was able to use amino acids, often described as life's building blocks, to design a new protein that was unlike any existing one, the academy said.

That opened the door to the rapid creation of different proteins for uses in areas such as pharmaceuticals, vaccines, nanomaterials and even tiny sensors.

"He developed computational tools that now enable scientists to design spectacular new proteins with entirely novel shapes and functions, opening endless possibilities for the greatest benefits to humankind," Heiner Linke, chair of the Nobel Committee for Chemistry, said of Baker's contribution.

In 2020, Hassabis and Jumper presented an AI model called AlphaFold2. With its help, they have been able to predict the structure of virtually all the 200 million proteins that researchers have identified, the academy said.

THIRD PRIZE ANNOUNCED

The third award to be handed out every year, the chemistry prize follows those for medicine and physics announced earlier this week.

The Nobel prizes were established in the will of dynamite inventor and wealthy businessman Alfred Nobel and are awarded to "those who, during the preceding year, shall have conferred the greatest benefit to humankind".

First handed out in 1901, 15 years after Nobel's death, it is awarded for achievements in medicine, physics, chemistry, literature and peace. Recipients in each category share the prize sum that has been adjusted over the years.

The economics prize is a later addition funded by the Swedish central bank.

Chemistry, close to Alfred Nobel's heart and the discipline most applicable to his own work as an inventor, may not always be the most headline-grabbing of the prizes, but past recipients include scientific greats such as radioactivity pioneers Ernest Rutherford and Marie Curie.

Last year's chemistry award went to Moungi Bawendi, Louis Brus and Aleksey Ekimov for their discovery of tiny clusters of atoms known as quantum dots, widely used today to create colours in flat screens, light emitting diode (LED) lamps and devices that help surgeons see blood vessels in tumours.

Alongside the cash prize, the winners will be presented a medal by the Swedish king on Dec. 10, followed by a lavish banquet in Stockholm city hall.

($1 = 10.3632 Swedish crowns)



Reporting by Johan Ahlander, Niklas Pollard and Marie Mannes in Stockholm; additional reporting by Terje Solsvik in Oslo, Anna Ringstrom in Stockholm and Martin Coulter in London; Editing by Alex Richardson

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.